A CITY OF FIRSTS IN LIFE SCIENCE AND HEALTHCARE
2
Home to the UK’s fastest growing regional economy, Manchester has established a strong reputation as an economic powerhouse and a competitive place to do business. A city of firsts, Manchester introduced In-Vitro Fertilisation (IVF) to the world, enabling the birth of over 8 million babies and pioneered the first total hip replacement surgery and bionic eye implants. Home to world-leading research and development assets as well as the largest clinical academic campus in Europe, the city region continues to be at the forefront of healthcare innovation. As the first UK city to have devolved control of its £6 billion health and social care budget, the region has developed a more streamlined pathway overseen by Health Innovation Manchester enabling companies to test and validate their innovations in an extended patient population of 11.8 million for local adoption and scale-up across the UK. The city region’s five universities boast a sustainable pipeline of graduate talent along with globally recognised clinical and research capabilities and world-leading biomedical and biotechnology centres where industry and academia can collaborate. This coupled with the region’s digital-first strategy and advanced materials expertise empowers companies to develop new tech-enabled solutions and explore the medical applications of new materials, such as Graphene in SMART and connected medical devices. £6 BILLION LOCAL HEALTH AND SOCIAL CARE BUDGET 2.8 MILLION POPULATION INTEGRATED CARE RECORD MORE SECTOR HIGHLIGHTS The Christie - a European leader and global top 50 specialist centre in cancer care World scientific lead in biomarker discovery and development Home to the first fully e-enabled NHS Trust - Salford Royal NHS Foundation Trust Home to Europe’s largest clinical academic campus UK’s first WHO age friendly city region 3rd largest Life Science cluster with the highest concentration of MedTech companies in the UK PRECISION MEDICINE Manchester hospitals were among the first NHS trusts in the UK to offer pioneering CAR-T therapy, revolutionising the treatment of leukaemia and lymphoma. Organisations such as The Christie, The University of Manchester’s Stoller Biomarker Discovery Centre, NIHR Biomedical Research Centre, Manchester Cancer Research Centre and MMPathic have helped to establish Manchester as a leading location for genomics, proteomics, and biomarker development for diagnostic and therapeutic applications. DIAGNOSTICS Built around a region rich in research intensive universities and with a long-standing history in medical technology and in-vitro diagnostics, the city region has been recognised by the UK government as “an exemplar site for new diagnostic and screening methodologies”, supporting faster uptake and deployment of new healthcare innovations. Manchester has been leading the way in COVID testing and analysis with Manchester-based companies alongside clinical and academic molecular expertise, developing nationally validated diagnostic tests and digitally enabled early warning systems for outbreak management across health and social care. A CITY OF FIRSTS IN LIFE SCIENCE AND HEALTHCARE
Transcript of A CITY OF FIRSTS IN LIFE SCIENCE AND HEALTHCARE
Home to the UK’s fastest growing regional economy, Manchester has established a strong reputation as an economic powerhouse and a competitive place to do business.A city of firsts, Manchester introduced In-Vitro Fertilisation (IVF) to the world, enabling the birth of over 8 million babies and pioneered the first total hip replacement surgery and bionic eye implants. Home to world-leading research and development assets as well as the largest clinical academic campus in Europe, the city region continues to be at the forefront of healthcare innovation.
As the first UK city to have devolved control of its £6 billion health and social care budget, the region
has developed a more streamlined pathway overseen by Health Innovation Manchester enabling companies to test and validate their innovations in an extended patient population of 11.8 million for local adoption and scale-up across the UK.
The city region’s five universities boast a sustainable pipeline of graduate talent along with globally recognised clinical and research capabilities and world-leading biomedical and biotechnology centres where industry and academia can collaborate. This coupled with the region’s digital-first strategy and advanced materials expertise empowers companies to develop new tech-enabled solutions and explore the medical applications of new materials, such as Graphene in SMART and connected medical devices.
£6 BILLION LOCAL HEALTH
AND SOCIAL CARE BUDGET
2.8 MILLION POPULATION INTEGRATED
CARE RECORD
MORE SECTOR HIGHLIGHTS
The Christie - a European leader and global top 50 specialist centre in cancer care
World scientific lead in biomarker discovery and development
Home to the first fully e-enabled NHS Trust - Salford Royal NHS Foundation Trust
Home to Europe’s largest clinical academic campus
UK’s first WHO age friendly city region
3rd largest Life Science cluster with the highest concentration of MedTech companies in the UK
PRECISION MEDICINEManchester hospitals were among the first NHS trusts in the UK to offer pioneering CAR-T therapy, revolutionising the treatment of leukaemia and lymphoma. Organisations such as The Christie, The University of Manchester’s Stoller Biomarker Discovery Centre, NIHR Biomedical Research Centre, Manchester Cancer Research Centre and MMPathic have helped to establish Manchester as a leading location for genomics, proteomics, and biomarker development for diagnostic and therapeutic applications.
DIAGNOSTICS Built around a region rich in research intensive universities and with a long-standing history in medical technology and in-vitro diagnostics, the city region has been recognised by the UK government as “an exemplar site for new diagnostic and screening methodologies”, supporting faster uptake and deployment of new healthcare innovations. Manchester has been leading the way in COVID testing and analysis with Manchester-based companies alongside clinical and academic molecular expertise, developing nationally validated diagnostic tests and digitally enabled early warning systems for outbreak management across health and social care.
A CITY OF FIRSTS IN LIFE SCIENCE AND HEALTHCARE
GET IN TOUCHMIDAS, Manchester’s dedicated inward investment agency, offers an extensive, free and confidential package of advice and assistance for potential investors and location consultants. MIDAS’ services are available to companies of all sizes that wish to relocate to or expand within Manchester.
To find out how we can help you, contact
Catherine Davidson Head of Business Development – Life Science and Healthcare
[email protected]+44 (0)161 237 4470@MIDAS_LifeSci @MIDAS_MCRinvestinmanchester.com
HEALTHY AGEING Manchester is recognised as the UK’s first age-friendly city region by the World Health Organisation, is one of Europe’s designated active and healthy ageing four-star reference sites and has been acknowledged by the Department for International Trade as a high potential investment opportunity location for health innovation for healthy ageing.
HEALTH ANALYTICS The region’s capabilities in bio-informatics, predictive healthcare modelling, data science and AI support and assist with risk, studying causes of disease and disability, and identifying new and effective treatments.
DIGITAL HEALTH Home to the first fully e-enabled NHS trust in England and global NHS digital exemplar, Manchester offers healthcare companies the market opportunity to access a fully integrated care record for 2.8 million patients for a deeper understanding of disease conditions, large clinical trials and health analytics enabling rapid market entry. Additionally, Manchester has the UK’s largest regional creative, digital and tech hub with strengths across technologies such as Cyber, IoT, AI and Data, meaning the city is uniquely placed for companies to explore and deliver their digital strategies for connected and integrated healthcare delivery.
MANCHESTER KEY FACTS
1 in 5200+
£62.8bn
Precision Medicine
DiagnosticsDigitalHealth
Healthy Ageing
Health Analytics
2.8m
40% 9.3%
people within one-hour commute
working age
population within
lower operating costs than London
economic growth2013-2018
businesses export
destinations connected by Manchester Airport
students
across five universities
ManchesterExpertise
GVA
Greater Manchesterpopulation > 100,000
7.2m 1.8m
IN GOOD COMPANY
